Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 24Neoplasm Metastasis 7Neoplasms 5Prostate Cancer Metastatic 4Carcinoma, Transitional Cell 4Recurrence 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Solid Cancer 1Small Cell Lung Carcinoma 1Penile Neoplasms 1Ovarian Neoplasms 1Nonseminomatous germ cell tumor 1Neoplastic Cells, Circulating 1Metastatic Castration-resistant Prostate Cancer 1Malignant Solid Tumor - Malignant Nervous System Neoplasm 1Lymphadenopathy 1Liposarcoma 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Breast Neoplasms 1Bone Metastatic Prostate Cancer 1Advanced Solid Tumor 1

Interventions

cabazitaxel 1XRP6258 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Solid Cancer × cabazitaxel × Clear all
NCT00925743 2013-05-16

A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer

Sanofi

Phase 1 Completed
76 enrolled

Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡